A5055380025- Central Venous Catheters and Hemodialysis
- Dialysis and Renal Disease Management
- Vascular Procedures and Complications
- Renal and Vascular Pathologies
- Renal Diseases and Glomerulopathies
- Venous Thromboembolism Diagnosis and Management
- Infectious Aortic and Vascular Conditions
- Heparin-Induced Thrombocytopenia and Thrombosis
- Atrial Fibrillation Management and Outcomes
- Blood Pressure and Hypertension Studies
- Vascular anomalies and interventions
- Acute Ischemic Stroke Management
- Erythropoietin and Anemia Treatment
- MRI in cancer diagnosis
- Peripheral Artery Disease Management
- Organ Donation and Transplantation
- Chronic Kidney Disease and Diabetes
- Iron Metabolism and Disorders
- Pharmacological Effects and Toxicity Studies
- Metastasis and carcinoma case studies
- Medication Adherence and Compliance
- Diabetes Management and Education
- Aortic aneurysm repair treatments
- Electrolyte and hormonal disorders
- Complement system in diseases
Rutgers New Jersey Medical School
2022
Rutgers, The State University of New Jersey
2022
Sprint (United States)
2021
SPRINT
2021
Duke Medical Center
1993-2016
University of Pennsylvania
2015
University of Iowa
2015
National Institute of Diabetes and Digestive and Kidney Diseases
2015
National Institutes of Health
2015
Duke University Hospital
1999-2000
Renal artery stenosis (RAS) is a relatively uncommon but important potentially reversible cause of renal failure. Little known about the natural history ischemic disease secondary to RAS. In previous reports, these researchers examined incidence and risk factors associated with The study presented here investigates long-term follow-up patients, specifically effect RAS on 4-yr, all-cause mortality in group 1235 patients undergoing diagnostic cardiac catheterization abdominal aortography. A...
The objective of this study was to investigate factors that might increase the risk epidural abscesses in hemodialysis patients. charts all patients presenting with an abscess over a period 5 yr at Duke University Hospital and Durham Veterans Administration Medical Center were reviewed for patient demographics, months on dialysis, vascular access, recently treated infections, signs symptoms presentation, results any surgical intervention. Ten developed during 5-yr period. Severe,...
Since the earliest reports of use Epoetin alfa in hemodialysis patients, it has been described that may exacerbate preexisting hypertension or induce End Stage Renal Disease (ESRD) patients not previously hypertensive. We undertook this study to determine if correction anemia ESRD with cardiac disease from a hematocrit 30 ± 3% 42 would result increased blood pressure. This was substudy "Normal Study".
Transient ST-segment depression measured on ambulatory ECG monitors has been described as representing silent ischemia. Patients who demonstrate ischemia have reported to show increased mortality compared patients without We undertook this study determine if the correction of anemia in End Stage Renal Disease (ESRD) from(± = standard deviation) 30 ± 3 42 with use Epoetin alfa would result decreased clinically evident ischemic heart disease or congestive failure.Methods: Thirty one ESRD...
We report the production, screening, and characterization of ten murine monoclonal antibodies directed at antigens that are expressed abnormally in human breast tumors. Immunoperoxidase staining frozen fixed tissues shows to be present low levels on luminal membrane normal cells high cytoplasm surface tumor cells. The appear recognize six different epitopes basis their quantitative differences reactivity against four antigen preparations, as measured by ELISA. Immunoblots show eight a...
No AccessJournal of UrologyUrological Survey: Abstracts: Kidney Transplantation and Renovascular Hypertension1 Dec 1998Survival in Renal Vascular Disease P.J. Conlon, K. Athirakul, E. Kovalik, S.J. Schwab, J. Crowley, R. Stack, C. B. Jr. McCants, D.B. Mark, T.M. Bashore, F. Albers ConlonP.J. Conlon More articles by this author , AthirakulK. Athirakul KovalikE. Kovalik SchwabS.J. Schwab CrowleyJ. Crowley StackR. Stack McCantsC. McCants MarkD.B. Mark BashoreT.M. Bashore AlbersF. View All...